p-Index From 2021 - 2026
3.936
P-Index
Claim Missing Document
Check
Articles

Benefit administration of vitamin B1, B6, and B12 on the depression symptom in hemodialysis patients Pinzon, Rizaldy Taslim; Ardiani, Birgitta Lisbethiara
Farmasains : Jurnal Farmasi dan Ilmu Kesehatan Vol 4, No 2 (2019): November
Publisher : University of Muhammadiyah Malang

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (1279.788 KB) | DOI: 10.22219/farmasains.v4i2.8919

Abstract

Chronic kidney disease (CKD) is a disease that causes a decrease in kidney function, which can be seen from GFR (Glomerulus Filtration Rate) value, which is less than 60 ml/minute/1.73 m2 in minimum three months. Depression is a psychological problem in a patient with chronic kidney disease undergoing hemodialysis. The previous study has shown that giving vitamin B combination can improve depression symptoms. To measure the benefit of vitamin B1, B6, B12 parenterally for depression symptoms in chronic kidney disease patients undergoing hemodialysis. This study used an experimental design (one group pre and post-test) in 117 patient that obtained using a consecutive sampling method. Depression score was measured by the HADS questionnaire before given vitamin B (pre-test) and after given vitamin B (post-test). Data were statistically analyzed using a licensed SPSS program with paired t-test/Non-Parametric Wilcoxon. The relationship between the history of the use of the antihypertensive, antidiabetic, folic acid drug, and depression scores were not showing significant results (p > 0.05). The relationship between administration of vitamins B1, B6, and B12 and the patient's depression score showed a decrease but not significant (p = 0.522). There was no significant difference after the administration of vitamin B1, B6, and B12 on the depression score of patients with chronic kidney disease undergoing hemodialysis at Bethesda and Panti Rapih Hospital in Yogyakarta.
EFFICACY AND SAFETY OF DULOXETINE IN THE TREATMENT OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY: A SYSTEMATIC REVIEW AND META-ANALYSIS Widyadharma, I Putu Eka; Vania Rau, Chiquita Putri; Pinzon, Rizaldy Taslim; Y, Yudiyanta; Indrayani, Agung Wiwiek; Purwata, Thomas Eko; Nugraha, Boya
MNJ (Malang Neurology Journal) Vol. 7 No. 1 (2021): January
Publisher : PERDOSSI (Perhimpunan Dokter Spesialis Saraf Indonesia Cabang Malang) - Indonesian Neurological Association Branch of Malang cooperated with Neurology Residency Program, Faculty of Medicine Brawijaya University, Malang, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21776/ub.mnj.2021.007.01.10

Abstract

Background: One of the adverse effects of chemotherapy in the neurological field is chemotherapy-induced peripheral neuropathy (CIPN), it was an adverse effect caused by many chemotherapeutic regimens and a major cause of continuous pain in patients who survived cancer. When the symptoms get worse, survivor’s quality of life is declining and they are often having problems with mental health, insomnia, cognitive functioning, fatigue, physical functioning, and pain. So far the choice of therapy for CIPN is still limited. Now, there was no drug approved to treat pain due to CIPN. Duloxetine are a SNRI (serotonin norepinephrine reuptake inhibitor), which it’s useful in CIPN are highly supported by evidence.Methods: We conducted a systemactic-computer based literature search on January 4, 2019 in PubMed database for article published between 2013 and 2018. We searched for a literature related with used a duloxetine for management of chemotherapy induced peripheral neuropathy.Results: From the 4 studies that included in this review, the total participants are 478 patients with neuropathic pain and already get a chemotherapy regiment. From the meta-analysis showed one study had no effect, two studies had small effect, and one study had medium effect.Conclusion: Duloxetine is a great option for the treatment of CIPN in especially reducing neuropathic pain.  
Peran Channelopathy pada Tatalaksana Nyeri Meliala, Lucas; Pinzon, Rizaldy Taslim; Sanyasi, Rosa De Lima Renita
Cermin Dunia Kedokteran Vol 44, No 12 (2017): Neurologi
Publisher : PT. Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (157.067 KB) | DOI: 10.55175/cdk.v44i12.689

Abstract

Latar Belakang: Tata laksana nyeri yang efektif sampai saat ini masih belum memuaskan. Pemahaman channelopathy diharapkan dapat meningkatkan kualitas penanganan nyeri. Tujuan: Kajian peran channelopathy pada nyeri. Pembahasan: Kanal ion yang terlibat dalam channelopathy pada nyeri adalah kanal natrium, kalsium, kalium, dan transient receptor potential (TRP). Channelopathy beberapa subtipe kanal TRP memicu penyakit FEPS tipe I dan berbagai gangguan sensitivitas nyeri. Channelopathy beberapa subtipe kanal kalsium dan kalium menimbulkan berbagai gangguan sensitivitas nyeri. Channelopathy kanal klorida tidak memicu gangguan sensitifitas nyeri. Saat ini telah ditemukan berbagai obat yang bekerja sebagai penghambat kerja kanal, sehingga dapat digunakan untuk terapi nyeri. Penelitian masih terus dilakukan hingga saat ini.Background: Treatment of pain remains challenging. Understanding channelopathy will hopefully improve pain treatment. Objective: To identify the role of channelopathy in pain mechanism. Discussion: Ion channels involved in channelopathy i.e: sodium channels, calcium channel, potassium channel, and transient receptor potential (TRP) channel. Channelopathy on some sodium channel subtypes lead to various diseases. Channelopathy on some TRP channels lead to FEPS type I and pain sensitivity disorder. Channelopathy on calcium and potassium channels lead to many pain sensitivity disorder. Channelopathy on chloride channels do not lead to pain sensitivity disorder. Many channels blocker drugs have been discovered. Knowledge of channelopathies will improve the quality of pain treatment.
Kejadian Disfagia saat Masuk Rumah Sakit sebagai Faktor Prognosis Buruk Luaran Klinis Pasien Stroke Iskemik Padma, Radha Govinda; Pinzon, Rizaldy Taslim; Pramudita, Esdras Ardi
Cermin Dunia Kedokteran Vol 44, No 1 (2017): Nutrisi
Publisher : PT. Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (149.053 KB) | DOI: 10.55175/cdk.v44i1.804

Abstract

Pendahuluan: Disfagia merupakan salah satu menifestasi pada pasien stroke iskemik. Disfagia memiliki kaitan dengan komplikasi pulmonal khususnya pneumonia, juga berkaitan dengan malnutrisi dan dehidrasi. Penelitian pengaruh disfagia terhadap luaran klinis masih terbatas dan hasilnya kontroversial. Tujuan: Menilai hubungan disfagia dengan luaran klinis buruk pada stroke iskemik. Metode: Studi kohort retrospektif terhadap 150 pasien berusia lebih dari 40 tahun. Subjek tercatat dalam stroke registry Rumah Sakit Bethesda Yogyakarta (2012-2015). Luaran klinis diukur dengan modified Rankin Scale (mRS). Data dianalisis univariat dilanjutkan dengan analisis bivariat dengan uji chi-square dan analisis multivariat dengan uji regresi logistik. Hasil: Data 150 pasien stroke iskemik terdiri dari 91 laki-laki (60.7%) dan 59 perempuan (39.3%). Sebanyak 49 pasien berusia lebih dari tujuh puluh tahun.Pasien dengan disfagia sebanyak 75 orang. 65 pasien di antaranya menunjukkan luaran klinis buruk (mRS≥2). Analisis bivariat menunjukkan beberapa variabel yang signifikan terhadap luran klinis buruk yaitu disfagia (RR: 2.241, 95% CI: 1.663 - 3.021, p:<0,001 ), jenis kelamin (RR: 0.688, 95%CI: 0.515 – 0.920, p:0,006), tingkat kesadaran (RR: 1,67, 95%CI: 1,30 – 2,16, p:<0,001), afasia (RR: 1.697, 95%CI: 1.406 - 2.048, p:<0,001), disartria (RR: 0.542, 95%CI: 0.327 - 0.900, p:0,002) dan kekuatan otot buruk (RR: 1,52, 95%CI: 0,67-3,44, p:0,021). Analisis multivariat menunjukkan bahwa disfagia secara independen memiliki hubungan dengan luaran klinis buruk pada stroke (RR: 2.022, 95%CI: 1.513-2.701, p:<0,001). Simpulan: Kejadian disfagia memiliki hubungan dengan luaran klinis buruk pada pasien stroke iskemik.Background: Dysphagia is one of manifestation in ischemic stroke. Dysphagia is associated with pulmonary complication especially pneumonia, malnutrition and dehydration. Studies on the impact of dysphagia on clinical outcomes are still limited and the results are controversial. Aim: To investigate the association between dysphagia in ischemic stroke with poor clinical outcome. Methods: A retrospective cohort study of 150 patients older than 40 year-old recorded in Stroke Registry Bethesda Hospital Yogyakarta (2012-2015).Clinical outcomes were evaluated with the modified Rankin Scale (mRS). Data analysis were univariate, bivariate followed by the chi-square and multivariate logistic regression. Results: Among 150 patients with ischemic stroke, ninety-one male (60.7%) and fifty-nine female (39.3%). Forty nine patients (32.7%) were more than 70 year-old. Dysphagia occured in 75 patients (50%) and 65 of those with poor functional outcome (mRS≥2). Bivariate analysis showed that variables significantly associated to clinical outcomes are dysphagia (RR: 2.241, 95% CI: 1.663 - 3.021, p:<0,001 ), gender (RR: 0.688, 95%CI: 0.515 – 0.920, p:0,006), consciousness (RR: 1,67, 95%CI: 1,30 – 2,16, p:<0,001), aphasia (RR: 1.697, 95%CI: 1.406 - 2.048, p:<0,001), dysarthria (RR: 0.542, 95%CI: 0.327 - 0.900, p:0,002) and poor muscle strength (RR: 1,52, 95%CI: 0,67-3,44, p:0,021). Multivariate analysis showed that dysphagia was independently associated with poor clinical outcome of stroke (RR: 2.022, 95%CI: 1.513-2.701, p:<0,001). Conclusion : Dysphagia is associated with poor functional outcome in ischemic stroke patients.
Terapi Rasional Nyeri Neuropatik Pinzon, Rizaldy
Cermin Dunia Kedokteran Vol 41, No 3 (2014): Farmakologi
Publisher : PT. Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (197.556 KB) | DOI: 10.55175/cdk.v41i3.1159

Abstract

Nyeri neuropatik dapat terjadi akibat lesi atau penyakit yang mengenai sistem somatosensorik. Penatalaksanaan nyeri neuropatik kronik masih sulit sekalipun sudah dilakukan sejumlah upaya untuk menghasilkan pendekatan terapi yang lebih rasional. Penggunaan NNT (number needed to treat) dan NNH (number needed to harm) patut dipertimbangkan dalam memilih obat untuk seorang pasien. Gabapentin, pregabalin, dan antidepresan trisiklik (tricyclic antidepressant, TCA) adalah obat-obat yang paling sering diteliti dan layak dipandang sebagai pilihan pertama dalam terapi nyeri neuropatik.Neuropathic pain may arise as a consequence of a lesion or disease affecting the somatosensory system. The management of chronic neuropathic pain is challenging, despite several attempts to develop a more rational therapeutic approach. The use of NNT (number needed to treat) and NNH (number needed to harm) should be considered for choosing the medications for individual patients. Gabapentin, pregabalin and TCA (tricyclic antidepressant) were the most frequently studied drugs and should be considered as first choices in treating neuropathic pain. 
Komorbiditas Nyeri pada Pasien Lanjut Usia Pinzon, Rizaldy
Cermin Dunia Kedokteran Vol 42, No 3 (2015): Nyeri
Publisher : PT. Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (174.532 KB) | DOI: 10.55175/cdk.v42i3.1028

Abstract

Latar belakang: Kondisi komorbiditas menyebabkan penggunaan obat jamak pada pasien lanjut usia dengan keluhan nyeri. Hal tersebut dapat meningkatkan risiko munculnya efek samping obat. Obat analgesik pada lanjut usia dapat mempengaruhi jantung, ginjal, otak, dan sistem gastrointestinal. Tujuan penelitian ini adalah mengukur prevalensi kondisi komorbiditas pada pasien lanjut usia dengan nyeri neuromuskuler. Metode: Penelitian potong lintang dengan metode sampling konsekutif. Subjek penelitian adalah pasien lanjut usia dengan nyeri neuromuskuler yang berobat ke poliklinik saraf RS Bethesda Yogyakarta periode Februari 2013-April 2013. Penilaian nyeri terstandar dilakukan pada semua pasien. Hasil: Data diperoleh dari 96 pasien lanjut usia (> 60 tahun), 52 laki-laki dan 44 perempuan. Kondisi nyeri neuromuskuler yang umum dijumpai adalah nyeri leher, nyeri lengan/ tungkai, dan nyeri punggung bawah. Sebagian besar pasien memiliki derajat nyeri sedang. Kondisi medis yang umum dijumpai adalah ulkus peptikum dan tekanan darah tinggi. Kondisi komorbiditas nyeri harus dipertimbangkan dalam tatalaksana nyeri. Simpulan: Sebagian besar pasien nyeri berusia lanjut memiliki kondisi komorbiditas. Kondisi ini harus dipertimbangkan dalam diagnosis dan tatalaksana nyeri.Background: Comorbidities in older adults lead to the use of multiple drugs, which is associated with an increased occurrence of adverse drug reaction. Analgesic drugs used in elderly may affect heart, kidney, brain, and GI tract. The aim of this study is to measure the prevalence of comorbidities conditions in elderlies with neuromuscular pain. Method: Cross sectional study with consecutive sampling method was used in this study. The subjects are elderly who came to neurology clinic from February 2013-April 2013 with neuromuscular pain condition. Standardized pain assessment was used in all patients. Result: The data were obtained from 96 elderly patients (age > 60 years old), consist of 52 male and 44 female. The most common neuromuscular problems are cervical pain, arm/ leg pain, and low back pain. Majority of patients come with moderate pain intensity. Medical comorbidities are very common, the most common are active peptic ulcer and high blood pressure. The presence of medical comorbidities should be taken into account in pain management. Conclusion: Majority of elderly pain patients suffered from other medical comorbidities. Coexisting conditions should be considered in diagnosis and therapy.
Proses Menua, Stres Oksidatif, dan Peran Anti Oksidan Zalukhu, Marta Lisnawati; Phyma, Agustinus Rudolf; Pinzon, Rizaldy Taslim
Cermin Dunia Kedokteran Vol 43, No 10 (2016): Anti-aging
Publisher : PT. Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (146.321 KB) | DOI: 10.55175/cdk.v43i10.870

Abstract

Penuaan ditandai dengan penurunan integritas fisiologis yang memicu gangguan fungsi, disebabkan oleh radikal bebas sebagai hasil stres oksidatif ditambah modifikasi genetik dan lingkungan. Membatasi atau menghambat reaksi radikal bebas untuk menurunkan laju perubahan akibat penuaan diharapkan dapat menurunkan tingkat penuaan dan patogenesis penyakit. Antioksidan merupakan molekul yang mampu menstabilkan atau menonaktifkan radikal bebas sebelum menyerang sel, juga dapat menghambat ataupun menunda oksidasi. Antioksidan memiliki fungsi preventif dan protektif terhadap penyakit terkait usia seperti penyakit kardiovaskular, kanker, kelainan neurodegeneratif, dan berbagai kondisi kronik lainnya.Aging is characterized by progressive loss of physiological integrity caused by free radical as result of oxidative stress, leading to impaired function, modifiable by genetic and enviromental factors. Interventions aimed at limiting or inhibiting the process should reduce the rate of changes with consequent reduction of aging rate and disease. Antioxidant refers to any molecule capable to stabilize or deactivate free radicals before they attack cells, also inhibit or delay the oxidation of a substrate. Antioxidant prevents and protects against age-related disease : cardiovascular disease, cancer, neurodegenerative disorders, and other chronic condition.
Perbandingan Tingkat Pencapaian Target Tekanan Darah oleh Lisinopril dan Valsartan pada Pasien Stroke Iskemik dengan Faktor Risiko Hipertensi Susanti, Susi; Pinzon, Rizaldy Taslim
Cermin Dunia Kedokteran Vol 45, No 4 (2018): Cidera Kepala
Publisher : PT. Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (110.942 KB) | DOI: 10.55175/cdk.v45i4.199

Abstract

Hipertensi  merupakan  salah  satu  faktor  risiko  terpenting  pada  stroke iskemik.  Terapi  antihipertensi  bertujuan  mencegah  kekambuhan  stroke. Tujuan penelitian ini adalah untuk membandingkan tingkat pencapaian tekanan darah antara lisinopril dan valsartan pada pasien stroke  iskemik dengan faktor risiko hipertensi di instalasi rawat jalan Rumah Sakit Bethesda Yogyakarta. Jenis penelitian adalah penelitian observasional analitik kohort retrospektif. Data dianalisis univariat dan bivariat dengan uji Chi-square atau uji Fisher. Data 108 pasien hipertensi pasca-stroke  iskemik terdiri  dari  kelompok  yang  diberi  valsartan  81  pasien  dan  lisinopril  27  pasien.  Target  tekanan  darah  yang  tercapai  pada  kelompok  valsartan  adalah 40 orang (49,4%) dan lisinopril 15 orang (50,9%), tidak berbeda bermakna (p value >0,05). Hasil penelitian menunjukkan tidak terdapat perbedaan dalam mencapai target tekanan darah antara lisinopril dan valsartan pada pasien stroke iskemik dengan faktor risiko hipertensi di instalasi rawat jalan Rumah Sakit Bethesda Yogyakarta.
The Benefits of Astaxanthin to Improve Pain Relief in Patients with Painful Diabetic Neuropathy: An Open-Label, Randomized Controlled Trial Pinzon, Rizaldy Taslim; Budi Harsana, Mary Rose Angelina
Pharmaceutical Sciences and Research Vol. 8, No. 3
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Treatment of diabetic neuropathy is still carried out by providing symptomatic therapy, which only improves ± 50% of the total symptoms felt by patients, but does not tackle the underlying causes of the disease. Astaxanthin is a potent antioxidant, anti-inflammatory, and anti-diabetic carotenoid that could be an additional treatment option. We aimed to measure the effectiveness of administering astaxanthin as an additional therapy to improve the impact of pain and discomfort experienced daily by diabetes mellitus patients with painful diabetic neuropathy. We conducted a randomized experimental study with an open label design of 36 patients who had been diagnosed with painful diabetic neuropathy. The control group was treated with standard treatment for painful diabetic neuropathy, and the experimental group was given both standard and additional therapy of astaxanthin at a dose of 6 mg once per day. The impact of pain was assessed using the Brief Pain Inventory (BPI) before administering astaxanthin and on the 4th and 8th weeks after administering astaxanthin. The administration of therapy showed a significant improvement in the impact of pain experienced daily by patients on both treatment groups (p<0.05). However, the mean BPI score of the control and the experimental groups did not differ significantly each week (p>0.05). There is a significant improvement in the BPI of patients with painful diabetic neuropathy who were given additional treatment (add on) of astaxanthin compared to patients who were only given standard treatment for painful diabetic neuropathy.
AGE-RELATED FACTORS OF EPILEPSY AND ITS IMPACT ON QUALITY OF LIFE: A CROSS-SECTIONAL STUDY IN BETHESDA HOSPITAL YOGYAKARTA Pinzon, Rizaldy Taslim; Wijono, Andre Dharmawan; Renita, Rosa De Lima
JAMBI MEDICAL JOURNAL "Jurnal Kedokteran dan Kesehatan" Vol. 8 No. 2 (2020): JAMBI MEDICAL JOURNAL Jurnal Kedokteran Dan Kesehatan
Publisher : FAKULTAS KEDOKTERAN DAN ILMU KESEHATAN UNIVERSITAS JAMBI

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (280.148 KB) | DOI: 10.22437/jmj.v8i2.5361

Abstract

Introduction: Epilepsy is a neurological disorder that negatively impacts quality of life (QOL). There are limited studies on the QOL of people living with epilepsy in Indonesia. Aim: The purpose of this study was to evaluate the association between age-related factors (age, age at onset, and duration of epilepsy) and QOL. Methods: This cross sectional study was conducted in the Department of Neurology, Bethesda Hospital, Yogyakarta, Indonesia from November 2017 to February 2018. Patients with epilepsy aged 18 years and above were recruited in the study. QOL was measured using the Short Form 8 (SF-8). Results: A total of 27 patients were eligible for the study. The QOL of patients aged ≥ 60 years was significantly lower in the following aspects: physical functioning (42.44±8.243), general health (40.04±7.641), role emotional (39.60±7.638), mental health (43.50±10.347), and mental component score (42.04±10.282). Patients with age at onset ≥ 55 years had significant effects in lower role emotional (40.54±7.245) and mental component score (42.98±10.155). There was no significant difference in the QOL scores and duration of epilepsy. Conclusion: This study demonstrated that age and age at onset influence the QOL in patients with epilepsy. Keywords: Epilepsy, age-related factors, quality of life, Short Form 8 Health Survey.
Co-Authors Adnyana, Kadek Sinthia Grahita Agung Endro Nugroho Agung Wiwiek Indrayani Agustinus Rudolf Phyma, Agustinus Rudolf Al Jody, Abraham Al Jody, Abraham Alexxander Alexxander, Alexxander Alfi Yasmina Alfi Yasmina Amboro, Wisnu Anak Agung Gede Sugianthara Angela, Angela Ardiani, Birgitta Lisbethiara Bagaskara, Arya T Basuki, Mudjiani Bisay, Vallentino Ardine Prasetya Budi Harsana, Mary Rose Angelina Bustami, Mursyid Ciptasari, Debora Purwasista Daniel Mahendra Krisna, Daniel Mahendra Desyandri Desyandri Digdoyo, Ananda Dodik Tugasworo Erna Kristin Esdras Ardi Pramudita, Esdras Ardi Fedora, Gusti Ayu Jacinda Amanda Ferdy Firmansyah Firdaus Hafidz As Shidieq Fithrie, Aida Fransiska Theresia Meivy Babang, Fransiska Theresia Meivy Gelgel, Putu Clara Shinta Hakim, Manfaluthy Hardi Astuti Witasari Hariatmoko Hariatmoko, Hariatmoko Hidayat, Muh. Faris I Putu Eka Widyadharma Ida Safitri Laksanawati Ika Puspitasari Iwan Dwiprahasto Jarir At Thobari Jesisca, Jesisca Johan Budiman Kadex Reisya Sita Damayanti Kriswanto Widyo, Kriswanto Kushartanti, Bernadeta Margareta Wara Lailla Affianti Fauzi Laksmi Asanti, Laksmi Lestari, MMA Dewi Lucas Meliala Maharani, Anyelir Dewi Maharani, Regina Vika Marpaung, Refianda Olivia Febrianti Mitasari, Pradita S Mugiono, Iroen Muhammad Hasnawi Haddani Muktiarini, Bernadetha Muslimah Muslimah Nani Kurniani Nathanael, Hanshel Everad Novita Intan Arovah Nugraha, Boya Padma, Radha Govinda Pagan Pambudi Pandita, Felicia Dara Puspitaning Paramitha, Dessy Pratiwi, Woro Rukmi Priskila, Loury Priskila, Loury Purwaka, Barlaam Bagus Purwaka Purwandityo, Ayuningtyas Galuh Purwantiningsih, Purwantiningsih Putra, I Dewa Gde Rainey Chrisananta Ratih Puspita Febrinasari Rendra, Andreas K. Renita Sanyasi, Rosa De Lima Renita Sanyasi, Rosa De Lima Renita, Rosa De Lima Rosa De Lima Renita Sanyasi, Rosa De Lima Renita Setyawan, Irfanianta Arif Sinaga, Ruth Vanessa Gloria Sinulingga, Zenine Charolin Siti Nurhayati Sudharmadji Sugianto Sugianto s Sugianto Sugianto Susanto, Agnes Susi Susanti Sutejo, Mianti Nurrizky Thomas Eko Purwata Tri Murti Andayani Trijayanti, Christiana Vania Rau, Chiquita Putri Veronica, Vanessa Vidyatama, Veren Amoreta Widyantanti, Maria Atika Sukmana Wijaya, Vincent Ongko Wijono, Andre Dharmawan Wuysang, Audry Devisanty Y, Yudiyanta Yacobus Christian Prasetyo Yolanda Dyah Kartika Zalukhu, Marta Lisnawati